Bullfrog AI Holdings Inc(BFRG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:43 PM ET (Korea 10/31 05:43)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.48 | Insider Own | 13.6% | Shs Outstand | 18.5M | Perf Week | -1.24% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | 5.22% | Shs Float | 16.0M | Perf Month | -22.38% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.09 | Inst Own | 5.87% | Short Float | 6.31% | Perf Quarter | -15.18% |
| Income | -0.01B | P/S | 30.14 | EPS this Y | - | Inst Trans | 9.06% | Short Ratio | 0.19 | Perf Half Y | -30.17% |
| Sales | 0.00B | P/B | 1.29 | EPS next 5Y | - | ROA | -113.54% | Short Interest | 1.01M | Perf YTD | -44.76% |
| Book/sh | 0.38 | P/C | 1.31 | EPS past 3/5Y | -10.94% -59.71% | ROE | -130.71% | 52W High | -75.12% ($1.96) | Perf Year | -61.9% |
| Cash/sh | 0.37 | P/FCF | - | Sales past 3/5Y | 126.81% - | ROIC | -85.82% | 52W Low | 14.73% ($0.43) | Perf 3Y | -82.71% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 38.11% | Gross Margin | 40.34% | Volatility(W/M) | 5.85% 10.79% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 7.37 | Sales Y/Y TTM | 798.45% | Oper. Margin | -2042.19% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.57 | EPS Q/Q | 51.17% | Profit Margin | -2006.87% | RSI (14) | 42.46 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.57 | Sales Q/Q | 547.64% | SMA20 | -11.5% ($0.55) | Beta | -2.72 | Target Price | - |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/09/02 | SMA50 | -12.19% ($0.56) | Rel Volume | 0.02 | Prev Close | $0.51 |
| Employees | 9 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -25.34% ($0.66) | Avg Volume(3M) | 5.29M | Price | $0.49 |
| IPO | 2023/2/14 | Option/Short | No/Yes | Trades | 318 | Volume | 125,199 | Change | -3.62% |
This company holds an exclusive license to technology from the Johns Hopkins University Applied Physics Laboratory (APL) and operates an AI platform designed for drug discovery and precision medicine, identifying novel drug targets and patient subgroups from biomedical data. Its end-to-end AI pipeline consists of three core platforms: bfLEAP®, the primary discovery engine; bfPREP™, a data preprocessing tool; and bfARENAS™, which supports clinical trial design. Through this integrated workflow, the company provides technology services to global pharmaceutical and biotech firms.
Over the past 1 year, on the lower side
75% below its 1-year high.
Traded less than usual. That is 2% of its average volume.
BFRG has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $3,014. Peers typically go for $76.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -82.7%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 5.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #35 of 41 in the industry
Based on market cap of $9M.
BFRG#35 Bullfrog AI Holdings Inc $9M PER - 
ACON#36 Aclarion Inc $6M PER - 
MGRX#37 Mangoceuticals Inc $5M PER - 
HCTI#38 Healthcare Triangle Inc $5M PER - 
ZCMD#39 Zhongchao Inc $5M PER - 
FAQ
What kind of company is BFRG?
BFRG belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of BFRG?
The market cap of BFRG is approximately $9M, ranking 5,464 within its sector.
What is the 52-week high and low for BFRG?
BFRG has recorded a 52-week high of $1.96 and a low of $0.43.
